Clinical Trial Update: Study of Lemborexant for Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease Dementia [Phase 2]

View source ↗

Summary

Phase 2 study of lemborexant for Irregular Sleep-Wake Rhythm Disorder has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease Dementia
• Irregular Sleep-wake Rhythm Disorder

Drugs mentioned

• Lemborexant (lemborexant)

Snippet

Sponsor: Eisai Inc. | Conditions: Irregular Sleep-Wake Rhythm Disorder | Phase 2 | Status: COMPLETED | Results posted: 2020-01-14